Clinical Trials
35
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (35 trials with phase data)β’ Click on a phase to view related trials
A Trial to Evaluate the Lot-to-lot Consistency of Live Attenuated Varicella Vaccine in Healthy People 1-12 Years of Age
- Conditions
- Varicella
- First Posted Date
- 2023-05-03
- Last Posted Date
- 2023-06-18
- Lead Sponsor
- China National Biotec Group Company Limited
- Target Recruit Count
- 1200
- Registration Number
- NCT05839301
- Locations
- π¨π³
Xinyi Center for Disease Control and Prevention, Xuzhou, Jiangsu, China
A Phase III Clinical Trial to Evaluate the Efficacy and Safety of the Live Attenuated Varicella Vaccine
- Conditions
- Varicella
- First Posted Date
- 2023-01-03
- Last Posted Date
- 2023-06-18
- Lead Sponsor
- China National Biotec Group Company Limited
- Target Recruit Count
- 12440
- Registration Number
- NCT05669625
- Locations
- π¨π³
Sinan County Center for Disease Control and Prevention, Tongren, Guizhou, China
π¨π³Songtao Miao Autonomous County Center for Disease Control and Prevention, Tongren, Guizhou, China
π¨π³Yuping Dong Autonomous County Center for Disease Control and Prevention, Tongren, Guizhou, China
Immunogenicity and Safety of BBIBP-Corv Coadministered With PPV23 and IIV4 in Hemodialysis Population
- Conditions
- HemolysisCOVID-19
- First Posted Date
- 2022-07-29
- Last Posted Date
- 2022-08-30
- Lead Sponsor
- China National Biotec Group Company Limited
- Target Recruit Count
- 1200
- Registration Number
- NCT05480436
- Locations
- π¨π³
Xiangya Hospital Central South University, Changsha, China
π¨π³Sichuan Center for Disease Control and Prevention, Chengdu, China
π¨π³Guizhou Center for Disease Control and Prevention, Guiyang, China
Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine (Sinopharm BBIBP-CorV) Coadministered With Rabies Vaccine
- Conditions
- COVID-19Rabies
- First Posted Date
- 2022-07-12
- Last Posted Date
- 2022-07-29
- Lead Sponsor
- China National Biotec Group Company Limited
- Target Recruit Count
- 360
- Registration Number
- NCT05453487
- Locations
- π¨π³
Guizhou Provincial Center for Disease Control and Prevention, Guiyang, China
π¨π³Shanxi Provincial Center for Disease Control and Prevention, Taiyuan, China
Sequential Immunization of Two Doses of Inactivated COVID-19 Vaccine (Omicron) in Vaccinated Population Aged 18 Years and Above
- Conditions
- COVID-19
- First Posted Date
- 2022-05-19
- Last Posted Date
- 2023-06-18
- Lead Sponsor
- China National Biotec Group Company Limited
- Target Recruit Count
- 1804
- Registration Number
- NCT05382871
- Locations
- ππ°
Queen Mary Hospital, Hong Kong, Hong Kong
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next